News | April 08, 2025
Lyka Labs secures Indian patent for Pregabalin Gel 8%
Pregabalin Gel 8% is a novel topical solution for diabetic neuropathic pain
Pregabalin Gel 8% is a novel topical solution for diabetic neuropathic pain
Lyka Labs has reported total income of Rs. 28.23 crores during the period ended September 30, 2023
The company has reported total income of Rs. 28.20 crores during the period ended June 30, 2022.
For the six months ended September 30, 2021, Lyka had reported revenues of Rs 109.87 crore
Lyka Labs has reported consolidated financial results for the period ended September 30, 2021
The company has been consistently reducing debt
Subscribe To Our Newsletter & Stay Updated
